Reduced NOD2 activation has been shown to inhibit autophagy in DCs altering both bacterial trafficking and MHCII-dependent antigen presentation.41 Our preliminary data may suggest that, in turn, reduced ATG16L1 function may inhibit bacterial dependent activation of NOD2, thereby altering the susceptibility to colitis. Here, NOD2 is linked to colitis.